Muscle maturation: Implications for gene therapy

Molecular Medicine Today

Volumn 4, Issue 5, 1998, Pages 214-220

  Van Deutekom, Judith C T ^a   Hoffman, Eric P ^b   Huard, Johnny ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; EXTRACELLULAR MATRIX; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS 1; MUSCLE DISEASE; RETROVIRUS; REVIEW; SKELETAL MUSCLE;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; HERPES; HUMAN HERPESVIRUS 1; UNIDENTIFIED RETROVIRUS;

EID: 0031860065     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(98)01231-3     Document Type: Review

References (50)

1. Blau H.M., Springer M.L. Molecular medicine: muscle-based gene therapy. New Engl. J. Med. 333:1995;1554-1556.
2. Svensson E.C., Tripathy S.K., Leiden J.M. Muscle-based gene therapy: realistic possibilities for the future. Mol. Med. Today. 2:1996;166-172.
3. Hoffman E.P., Brown R.H. Jr., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 51:1987;919-928.
4. Watkins S.C., Hoffman E.P., Slayter H.S., Kunkel L.M. Immuno-electron microscopic localization of dystrophin in myofibers. Nature. 333:1988;863-866.
5. Acsadi G.et al. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature. 352:1991;815-818.
6. Dunckley M.G.et al. Retroviral-mediated transfer of a dystrophin minigene into mdx mouse myoblasts in vitro. FEbs Lett. 296:1992;128-134.
7. Ragot T.et al. Efficient adenovirus-mediated transfer of a human mini-dystrophin gene to skeletal muscle of mdx mice. Nature. 361:1993;647-650.
8. Vincent N.et al. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a mini-dystrophin gene. Nat. Genet. 5:1993;130-134.
9. Partridge T.A.et al. Conversion of mdx myofibers from dystrophin negative to positive by injection of normal myoblasts. Nature. 337:1989;176-179.
10. Karpati G.et al. Myoblast transfer in Duchenne muscular dystrophy. Ann. Neurol. 34:1993;8-17.
11. Tremblay J.P.et al. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant. 2:1993;99-112.
12. Beauchamp J.R., Morgan J.E., Pagel C.N., Partridge T.A. Quantitative studies of efficacy of myoblast transplantation. Muscle Nerve. 18:1994;S261.
13. Huard J.et al. Gene transfer into skeletal muscles by isogenic myoblasts. Hum. Gene Ther. 5:1994;949-958.
14. Mendell J.R.et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. New Engl. J. Med. 333:1995;832-838.
15. Gussoni E., Blau H.M., Kunkel L.M. The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat. Med. 3:1997;970-977.
16. Guerrette B.et al. Control of inflammatory damage by anti-LFA-1: increase success of myoblast transplantation. Cell Transplant. 6:1997;101-107.
17. Wolff J.A.et al. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1:1992;363-369.
18. Davis H.L.et al. Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum. Gene Ther. 4:1993;733-740.
19. Davis H.L., Whalen R.G., Demeneix B.A. Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 4:1993;151-159.
20. Doh S.G.et al. Spatial-temporal patterns of gene expression in mouse skeletal muscle after injection of LacZ plasmid DNA. Gene Ther. 4:1997;648-663.
21. Vitiello L.et al. Condensation of plasmid DNA with polylysine improves liposome-mediated gene transfer into established and primary muscle cells. Gene Ther. 3:1996;396-404.
22. Feero W.G.et al. Selection and use of ligands for receptor-mediated gene delivery to myogenic cells. Gene Ther. 4:1997;664-674.
23. Barr E., Leiden J.M. Systemic delivery of recombinant proteins by genetically modified myoblasts. Science. 254:1991;1507-1509.
24. Dhawan J.et al. Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science. 254:1991;1509-1512.
25. Salvatori G.et al. Retroviral-mediated gene transfer into human primary myogenic cells lead to expression in muscle fibers in vivo. Hum. Gene Ther. 4:1993;713-723.
26. Miller D.G., Adam M.A., Miller A.D. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10:1990;4239-4242.
27. Acsadi G.et al. A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum. Mol. Genet. 3:1994;579-584.
28. Quantin B., Perricaudet L.D., Tajbakhsh S., Mandel J.L. Adenovirus as an expression vector in muscle cells in vivo. Proc. Natl. Acad. Sci. U. S. A. 89:1992;2581-2584.
29. Acsadi G.et al. Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Hum. Gene Ther. 7:1996;129-140.
30. Kochanek S.et al. A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase. Proc. Natl. Acad. Sci. U. S. A. 93:1996;5731-5736.
31. Kumar-Singh R., Chamberlain J.S. Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells. Hum. Mol. Genet. 5:1996;913-921.
32. Haecker S.E.et al. In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes. Hum. Gene Ther. 7:1996;1907-1914.
33. Huard J.et al. The basal lamina is a physical barrier to herpes simplex virus-mediated gene delivery to mature muscle fibers. J. Virol. 70:1996;8117-8123.
34. Huard J.et al. LacZ gene transfer to skeletal muscle using a replication-defective herpes simplex virus type 1 mutant vector. Hum. Gene Ther. 8:1997;439-452.
35. Huard J.et al. Gene transfer to muscle using herpes simplex virus-based vectors. Neuromusc. Disord. 7:1997;1-15.
36. Xiao X., Li J., Samulski R.J. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70:1996;8098-8108.
37. Fisher K.J.et al. Recombinant adeno-associated virus for muscle directed gene therapy. Nat. Med. 3:1997;306-312.
38. Johnson P.A.et al. Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. J. Virol. 66:1992;2952-2965.
39. Vilquin J.T.et al. FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. Hum. Gene Ther. 6:1995;1391-1401.
40. Guerette B.et al. Prevention of immune reactions triggered by first-generation adenoviral vectors by monoclonal antibodies and CTLA4Ig. Hum. Gene Ther. 7:1996;1455-1463.
41. Chen H.H.et al. Persistence in muscle of an adenoviral vector that lacks all viral genes. Proc. Natl. Acad. Sci. U. S. A. 94:1997;1645-1650.
42. Feero W.G.et al. Viral gene delivery to skeletal muscle: insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type 1 viral vectors. Hum. Gene Ther. 8:1997;371-380.
43. Acsadi G.et al. Cultured human myoblasts and myotubes show markedly different transducibility by replication-defective adenovirus recombinants. Gene Ther. 1:1994;338-340.
44. Wickham T.J.et al. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nat. Biotechnol. 14:1996;1570-1573.
45. Yurchenco P.D. Assembly of basement membranes. Ann. New York Acad. Sci. 580:1990;195-213.
46. Xu H.et al. Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc. Natl. Acad. Sci. U. S. A. 91:1994;5572-5576.
47. Danko I.et al. Pharmacological enhancement of in vivo foreign gene expression in muscle. Gene Ther. 1:1994;114-121.
48. Vitadello M.et al. Gene transfer in regenerating muscle. Hum. Gene Ther. 5:1994;11-18.
49. Booth D.K.et al. Myoblast mediated ex vivo gene transfer to mature muscle. Tissue Eng. 3:1997;125-133.
50. Floyd S.S.et al. Ex vivo gene transfer using adenovirus mediated full-length dystrophin delivery to mature dystrophic muscles. Gene Ther. 5:1998;19-30.